TESSP5 Inhibitors
Chemical inhibitors of TESSP5 play a crucial role in modulating the activity of this protein by interfering with specific pathways and enzymes that are essential for its function. Palbociclib, for example, selectively targets CDK4 and CDK6, key kinases in cell cycle regulation. By inhibiting these kinases, Palbociclib can prevent the phosphorylation of retinoblastoma protein, thereby halting the transition from the G1 phase to the S phase of the cell cycle, which impairs the regulatory function of TESSP5. Similarly, Trametinib and Cobimetinib inhibit MEK1 and MEK2, respectively, which are components of the MEK/ERK pathway. This pathway is integral to the phosphorylation events that TESSP5 relies on for signal transduction related to cell proliferation and differentiation. As a result, TESSP5's activity is decreased due to the lack of necessary phosphorylation by ERK.
Further along the signaling cascade, Alpelisib, Buparlisib, and Omipalisib disrupt the PI3K/Akt/mTOR pathway by inhibiting the alpha isoform of PI3K and, in some cases, mTOR kinases directly. This action results in a reduction of Akt phosphorylation and mTOR activity, which are pivotal for growth factor signaling processes involving TESSP5. Everolimus, Sapanisertib, Temsirolimus, and Rapamycin are mTOR inhibitors that prevent the activation of this kinase, leading to decreased protein synthesis and cell cycle arrest. This can inhibit the functional activity of TESSP5 in processes such as protein synthesis and cell proliferation. Other inhibitors like WYE-354, AZD8055, Torin 1, and OSI-027 are known to target mTOR directly, affecting both mTORC1 and mTORC2 complexes to curb the cellular processes that TESSP5 promotes. Finally, PI-103, KU-0063794, PF-04691502, and GDC-0941 act on PI3K and/or mTOR, leading to a disrupted signaling in pathways where TESSP5 is active, particularly affecting cell survival and growth, thereby inhibiting TESSP5's functional role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and the resulting complex inhibits mTORC1. TESSP5, involved in cell cycle progression, would be functionally inhibited by the reduction of mTORC1 activity, leading to decreased cell proliferation and growth. | ||||||
WYE-354 | 1062169-56-5 | sc-364652 sc-364652A | 10 mg 50 mg | $286.00 $1200.00 | ||
WYE-354 directly inhibits mTOR, leading to decreased downstream signaling necessary for cell growth and proliferation. This inhibition would disrupt processes in which TESSP5 is involved, thereby functionally inhibiting TESSP5. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 is a potent ATP-competitive inhibitor of mTOR kinase activity, affecting both mTORC1 and mTORC2. Inhibition of these complexes would result in reduced activity of TESSP5 by hindering cellular growth signals. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Torin 1 is a potent and selective mTOR inhibitor that affects both mTORC1 and mTORC2. By inhibiting mTOR, Torin 1 would suppress the cellular processes that are necessary for TESSP5's function in cell growth and metabolism. | ||||||
OSI-027 | 936890-98-1 | sc-364557 sc-364557A | 10 mg 50 mg | $437.00 $1186.00 | 1 | |
OSI-027 is a selective ATP-competitive mTOR inhibitor, affecting both mTORC1 and mTORC2. By inhibiting these complexes, OSI-027 would decrease the functional activity of TESSP5 associated with cell proliferation and survival. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
PI-103 is a potent inhibitor of PI3K and mTOR, leading to disrupted signaling in pathways where TESSP5 is active, particularly affecting cell survival and growth, thereby inhibiting TESSP5 functionally. | ||||||
KU 0063794 | 938440-64-3 | sc-361219 | 10 mg | $209.00 | ||
KU-0063794 is a selective inhibitor of mTORC1 and mTORC2. This inhibition would functionally inhibit TESSP5 by hindering the mTOR signaling pathway, which is involved in cell growth and proliferation where TESSP5 plays a role. | ||||||
ZSTK 474 | 475110-96-4 | sc-475495 | 5 mg | $75.00 | ||
ZSTK474 inhibits PI3K, leading to reduced Akt activation and subsequent downstream signaling that is crucial for cell growth and survival. This would functionally inhibit TESSP5 by disrupting the signaling pathways it is involved in. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941 is a potent inhibitor of PI3K. By inhibiting PI3K, it hinders the Akt pathway, subsequently affecting cell survival and proliferation. This would result in the functional inhibition of TESSP5's role in these processes. | ||||||